FIELD: medicine, pharmaceutics.
SUBSTANCE: there are described novel acylsulfonamide peri-substituted condensed bicyclic compounds of general formula (I), values of radicals are given in invention formula. Also described is pharmaceutical composition based on formula (I) compound.
EFFECT: compounds can be used for inhibition of prostaglandin E2 binding with receptor EP3.
30 cl, 371 ex, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2711502C2 |
MODULATORS OF ATP-BINDING CARTRIDGE TRANSPORTERS | 2005 |
|
RU2528046C2 |
METHOD OF MODULATING TRANSPORTERS OF ATP-BINDING CASSETTE | 2005 |
|
RU2525115C2 |
ATP-BINDING CASETTE TRANSPORTER MODULATORS | 2005 |
|
RU2382779C2 |
MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | 2005 |
|
RU2556984C2 |
PERI-SUBSTITUTED ARYLSULPHONAMIDE BICYCLIC COMPOUNDS FOR TREATING ARTERY OCCLUSIVE DISEASES | 2005 |
|
RU2407736C2 |
PHOSPHOINDOLES AS HIV INHIBITORS | 2005 |
|
RU2393163C2 |
KINASE INHIBITORS APPLICABLE FOR TREATING MYELOPROLIFERATIVE DISEASES AND OTHER PROLIFERATIVE DISEASES | 2007 |
|
RU2482112C2 |
2,6-SUBSTUTED-4-MONOSUBSTITUTED AMINO-PYRIMIDINES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS | 2005 |
|
RU2417990C2 |
HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2014 |
|
RU2681849C2 |
Authors
Dates
2010-11-10—Published
2005-06-27—Filed